Warren Hosseinion - Sep 1, 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
President, Director
Signature
/s/ Warren Hosseinion
Stock symbol
NUTX
Transactions as of
Sep 1, 2022
Transactions value $
$905,358
Form type
4
Date filed
9/6/2022, 04:52 PM
Previous filing
May 11, 2022
Next filing
Sep 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Sale $179K +70K +7.7% $2.56* 979K Sep 1, 2022 Direct F1
transaction NUTX Common Stock Sale $447K +180K +29.08% $2.48* 799K Sep 2, 2022 Direct F2
transaction NUTX Common Stock Sale $279K +100K +16.7% $2.79* 699K Sep 6, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5445 to $2.5840, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4009 to $2.5031, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7500 to $2.8271, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.